YOUR FAVORITE GENES IN YOUR FAVORITE CELL
Live / Registered — Registered (as of 06 Oct 2020)
What this means for you
Registered since 06 Oct 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87069198
- Registration number
- 6166553
- Mark type
- Stylized text
- Filed
- 13 Jun 2016
- Published for opposition
- 23 May 2017
- Registered
- 06 Oct 2020
- Attorney of record
- Courtney Thompson
Goods and services
- Class 042 — Scientific and technological services: Custom cell-line engineering services; Scientific research in the field of genetics and genetic engineering, namely, gene-editing services, DNA modeling services, gene engineering services, establishing patient genotypes; Bio-technology, pharmaceutical and scientific testing for scientific research purposes, research and development services relating to genetics; biological research; pharmaceutical research services; drug discovery services; Scientific research and development services for lead identification and validation; Scientific research and development services for target identification and validation; Pharmaceutical research, namely, identification of patient-relevant drug targets, optimization of drug candidates for clinical development; Laboratory diagnostic services for research purposes, namely, diagnosis of genetic mutations for clinical or research purposes and the design of molecular reference standards for assay development, clinical diagnostic quality control and proficiency schemes for the medical diagnostic services industry; medicinal research services, namely, hit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lines, chemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; Scientific research and development services relating to targeting therapies to individuals; Scientific research and development services relating to combining therapies for individuals; research and development relating to reagents; Scientific research in the field of disease modeling; Medical and scientific research, namely, designing and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indications
Owner
- RESEARCH AND DIAGNOSTIC SYSTEMS, INC., MINNEAPOLIS, MN, US
- B-MoGen Biotechnologies, Inc., Minneapolis, MN, US
- B-MoGen Biotechnologies, Inc., Minneapolis, MN, US
- B-MoGen Biotechnologies, Inc., Minneapolis, MN, US
Prosecution history
- 06 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Aug 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 May 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 May 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 May 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 08 May 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 May 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 May 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 01 Sept 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 02 Jul 2020 — NOTICE OF ALLOWANCE CANCELLED
- 27 Aug 2020 — PETITION TO DIRECTOR DISMISSED
- 28 Aug 2020 — NOTICE OF REINSTATEMENT E-MAILED
- 27 Aug 2020 — REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
- 27 Aug 2020 — ASSIGNED TO PETITION STAFF